FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W748656056> ?p ?o ?g. }

• W748656056 endingPage "839" @default.
• W748656056 startingPage "839" @default.
• W748656056 abstract "Article1 April 1958INTRA-ARTERIAL NITROGEN MUSTARD IN THE TREATMENT OF PELVIC CANCERIRWIN H. KRAKOFF, M.D., ROBERT D. SULLIVAN, M.D.IRWIN H. KRAKOFF, M.D.Search for more papers by this author, ROBERT D. SULLIVAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-48-4-839 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn advanced and nonresectable neoplastic disease certain chemical agents have been found to have some effect in slowing the growth or in producing temporary regression of the tumor tissue. Nearly all of the agents which are capable of producing such effects, when administered systemically, also have toxic effects on the bone marrow, liver or other organs. Host toxicity is the limiting factor in dosage, and prevents the use of sufficient amounts of drug to produce drastic effects on the tumor.Klopp et al.1-4reported that in patients with inoperable cancer in whom the principal manifestations of the disease were largely...Bibliography1. KloppBatemanBerryAlfordWinship CTJCNCT: Fractionated regional cancer chemotherapy, Cancer Research 10: 229, 1950. Google Scholar2. KloppAlfordBatemanBerryWinship CTTCJCGNT: Fractionated intra-arterial cancer chemotherapy with methyl bis amine hydrochloride: a preliminary report, Ann. Surg. 132: 811, 1950. CrossrefMedlineGoogle Scholar3. BatemanKloppCromer JCCTJK: Hematologic effects of regional nitrogen mustard therapy, Blood 6: 26, 1951. CrossrefMedlineGoogle Scholar4. CromerBatemanBerryKennellyKloppPlatt JKJCGNJMCTLI: Use of intra-arterial nitrogen mustard therapy in the treatment of cervical and vaginal cancer, Am. J. Obst. and Gynec. 63: 538, 1952. CrossrefMedlineGoogle Scholar5. BiermanShimkinByronMiller HRMBRLER: The effects of intra-arterial administration of nitrogen mustard. V. Congrès internationale du Cancer, 1950, Hermann, Paris, p. 186. Google Scholar6. BiermanByronKelly HRRLKH: Therapy of inoperable visceral and regional metastases by intra-arterial catheterization in man, Cancer Research 11: 236, 1951. Google Scholar7. BonnerThurmanHomburger CDAF: A critical study of regional intra-arterial nitrogen mustard therapy in cancer, Ann. Surg. 136: 912, 1952. CrossrefMedlineGoogle Scholar8. GradyKrantzBrown EGSPF: Treatment of cancer by intermittent injection of nitrogen mustard via cannulated arteries, Ann. Surg. 137: 366, 1953. CrossrefMedlineGoogle Scholar9. BoimanHolzaepfelBarnes REJHAC: Intra-arterial nitrogen mustard in advanced pelvic malignancies, Am. J. Obst. and Gynec. 72: 1319, 1956. CrossrefMedlineGoogle Scholar10. SullivanJonesSchnabelShorey RDRTGJM: The treatment of human cancer with intra-arterial nitrogen mustard (methyl bis (2-chloroethyl) amine hydrochloride) utilizing a simplified catheter technique, Cancer 6: 121, 1953. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication August 26, 1957.From the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, the Chemotherapy Service of Memorial and James Ewing Hospitals, and the Department of Medicine, Cornell University Medical College.†These studies were supported by research grants C1889 and CY3215 from the National Cancer Institute of the National Institutes of Health, Public Health Service; institutional grants from the American Cancer Society, the Damon Runyon Memorial Fund for Cancer Research, the Lasker Foundation and the Black-Stevenson Foundation.‡Present address: Manhattan Veterans Administration Hospital, New York, N. Y.Requests for reprints should be addressed to Irwin H. Krakoff, M.D., Memorial Center for Cancer and Allied Diseases, 444 East Sixty-eighth Street, New York 21, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byPelvic Perfusion for Advanced Colorectal CancersNew Methods of Chemotherapy Administration-Selected RoutesTranscatheter Management of NeoplamsMullerian adenosarcoma of the uterine cervixGynecologic MalignancyClinical Science Review: Regional Perfusion for Malignant Melanoma and Soft Tissue Sarcoma: A ReviewInfusion–embolizationIntra-Arterial Perfusion Therapy with 5-Fluorouracil In Patients with Metastatic Colorectal Carcinoma and Intractable Pelvic PainIntraarterial infusion chemotherapy (5-fluorouracil) in patients with inextirpable or locally recurrent rectal cancerMedical Treatment of Advanced Carcinoma of the Cervix. A ReviewLocal and Regional ChemotherapyRegional ChemotherapyTreatment of Gastrointestinal Cancer: Current Status and Recent ProgressCurrent Status of Protracted Arterial Infusion Cancer Chemotherapy for the Treatment of Solid TumorsChemotherapy of advanced cancer of the cervixProlonged intra-arterial therapy for advanced pelvic malignancyPALLIATIVE TREATMENT OF ADVANCED CERVICAL CARCINOMA BY INTRA-AORTIC INJECTION OF NITROGEN MUSTARDCombined intra-arterial chemotherapy and radiation treatment for advanced cervical carcinomaUPPER HEMIBODY INFUSION WITH ALKYLATING AGENTS FOR ADVANCED LUNG CANCERCHEMOTHERAPY OF CERVICAL CARCINOMA*Continuous Arterial Infusion Cancer ChemotherapyCancer Chemotherapy in the Urologic PatientXXXIV The Treatment of Head and Neck Cancer with the Continuous Arterial Infusion of Methotrexate and the Intermittent Intramuscular Administration of Citrovorum FactorProlonged intra-arterial chemotherapy for inoperable cancer: A techniquePerfusion and Infusion Techniques in Cancer ChemotherapyPelvic perfusion with nitrogen mustard for cancer: a neurological complicationTreatment of Malignant Pelvic Tumors by Extracorporeal Perfusion with Chemotherapeutic AgentsAntimetabolite-metabolite combination cancer chemotherapy.Effects of intra-arterial methotrexate—intramuscular citrovorum factor therapy in human cancer 1 April 1958Volume 48, Issue 4Page: 839-850KeywordsCancer chemotherapyChemotherapyHospital medicineLiverLymphomaMedical servicesPrevention, policy, and public healthResearch fundingResearch grantsToxicity Issue Published: 1 April 1958 PDF downloadLoading ..." @default.
• W748656056 created "2016-06-24" @default.
• W748656056 date "1958-04-01" @default.
• W748656056 modified "2023-09-24" @default.
• W748656056 title "INTRA-ARTERIAL NITROGEN MUSTARD IN THE TREATMENT OF PELVIC CANCER" @default.
• W748656056 cites W1986219447 @default.
• W748656056 cites W2034586008 @default.
• W748656056 cites W2045565618 @default.
• W748656056 cites W2086880903 @default.
• W748656056 cites W2181816749 @default.
• W748656056 cites W2268345042 @default.
• W748656056 cites W76272731 @default.
• W748656056 doi "https://doi.org/10.7326/0003-4819-48-4-839" @default.
• W748656056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13521609" @default.
• W748656056 hasPublicationYear "1958" @default.
• W748656056 type Work @default.
• W748656056 sameAs 748656056 @default.
• W748656056 citedByCount "34" @default.
• W748656056 crossrefType "journal-article" @default.
• W748656056 hasConcept C121608353 @default.
• W748656056 hasConcept C126322002 @default.
• W748656056 hasConcept C141071460 @default.
• W748656056 hasConcept C2776694085 @default.
• W748656056 hasConcept C2776755627 @default.
• W748656056 hasConcept C2778670039 @default.
• W748656056 hasConcept C29730261 @default.
• W748656056 hasConcept C71924100 @default.
• W748656056 hasConceptScore W748656056C121608353 @default.
• W748656056 hasConceptScore W748656056C126322002 @default.
• W748656056 hasConceptScore W748656056C141071460 @default.
• W748656056 hasConceptScore W748656056C2776694085 @default.
• W748656056 hasConceptScore W748656056C2776755627 @default.
• W748656056 hasConceptScore W748656056C2778670039 @default.
• W748656056 hasConceptScore W748656056C29730261 @default.
• W748656056 hasConceptScore W748656056C71924100 @default.
• W748656056 hasIssue "4" @default.
• W748656056 hasLocation W7486560561 @default.
• W748656056 hasLocation W7486560562 @default.
• W748656056 hasOpenAccess W748656056 @default.
• W748656056 hasPrimaryLocation W7486560561 @default.
• W748656056 hasRelatedWork W2002120878 @default.
• W748656056 hasRelatedWork W2003938723 @default.
• W748656056 hasRelatedWork W2047967234 @default.
• W748656056 hasRelatedWork W2118496982 @default.
• W748656056 hasRelatedWork W2364998975 @default.
• W748656056 hasRelatedWork W2369162477 @default.
• W748656056 hasRelatedWork W2439875401 @default.
• W748656056 hasRelatedWork W4238867864 @default.
• W748656056 hasRelatedWork W2519357708 @default.
• W748656056 hasRelatedWork W2525756941 @default.
• W748656056 hasVolume "48" @default.
• W748656056 isParatext "false" @default.
• W748656056 isRetracted "false" @default.
• W748656056 magId "748656056" @default.
• W748656056 workType "article" @default.